Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial

References

• ADVANCE management committeeStudy rationale and design of ADVANCE: action in diabetes and vascular disease–Preterax and Diamicron MR controlled evaluationDiabetologia20014411182011596665
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupDiuretic versus α-blocker as first-step antihypertensive therapy. Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)Hypertension2003422394612925554
   PubMed Web of Science ®Google Scholar
• AmarJVaurLPerretMOn behalf of the PRATIK study investigators. Hypertension in high-risk patients : beware of the underuse of effective combination therapy (results of the PRATIK study)J Hypertens2002207798411910316
   PubMed Web of Science ®Google Scholar
• AsmarRGLondonGMO’RourkeMEImprovement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenololHypertension200138922611641310
   PubMed Web of Science ®Google Scholar
• ChalmersJCastaigneAMorganTLong-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibi-tor/diuretic combination as first-line therapy in elderly hypertensive patientsJ Hypertens2000183273710726720
   PubMed Web of Science ®Google Scholar
• ChamontinBLangTVaisseB[Regional management of arterial hypertension in France. Report of a survey of general practitioners]Arch Mal Coeur Vaiss200194823711575211
   PubMedGoogle Scholar
• ChobanianAVBakrisGLBlackHRThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• CushmanWCFordCECutlerJASuccess and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)J Clin Hypertens (Greenwich)2002439340412461301
   PubMedGoogle Scholar
• DahlofBGossePGueretPPerindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL studyJ Hypertens20052320637016208150
   PubMed Web of Science ®Google Scholar
• de LucaNMallionJMO’RourkeMFRegression of left ventricular mass in hypertensive patients treated with perindopril/in-dapamide as a first-line combination: the REASON echocardiography studyAm J Hypertens200417660715323062
   PubMed Web of Science ®Google Scholar
• [ESH-ESC]2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032110115312777938
   PubMed Web of Science ®Google Scholar
• FranklinSSLarsonMGKhanSADoes the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart StudyCirculation20011031245911238268
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study GroupLancet19983511755629635947
   PubMed Web of Science ®Google Scholar
• Haute Autorité de SantéPrise en charge des patients adultes atteints d’hypertension artérielle essentielle (Management of adult patients with essential arterial hypertension. Recommendations)—Recommenda-tions. 2005 Update [online]2005 Accessed:July 2006. URL: http://www.sfhta.org/pdf/2RecoHTA2005.pdf
   Google Scholar
• The Heart Outcomes Prevention Evaluation Study InvestigatorsEffects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudyLancet2000355253910675071
   PubMed Web of Science ®Google Scholar
• HolzgreveHRislerTTrenkwalderPEfficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS studyCurr Med Res Opin20062218495816968588
   PubMed Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trialLancet200436320223115207952
   PubMed Web of Science ®Google Scholar
• KawataTMasaoDReiHEffect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonistAm Heart J2006151798.e9798.e1516569537
   PubMed Web of Science ®Google Scholar
• LondonCMAsmarRGO’RourkeMMechanism(s) of selective Systolic Blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenololJ Am Coll Cardiol20044392914715189
   PubMed Web of Science ®Google Scholar
• ManciaGPessinaACTrimarcoBSILVIA (Studio Italiano Longitudinale sulla valutazione della Ipertensione Arteriosa nel 2000) Study groupBlood pressure control according to new guidelines targets in low-to high-risk hypertensives managed in specialist practiceJ Hypertens20042223879615614034
   PubMed Web of Science ®Google Scholar
• MatersonBJRedaDJCushmanWCResults of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Antihypertensive AgentsJ Hum Hypertens1995979168576893
   PubMedGoogle Scholar
• MogensenCEVibertiGHalimiSEffect of low-dose perin-dopril/indapamide on albuminuria in diabetes: Preterax in albuminuria regression: PREMIERHypertension20034110637112654706
   PubMed Web of Science ®Google Scholar
• MouradJJHanonODeverreJRImprovement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibi-tor/diuretic therapy : a pilot PET studyJ Renin Angiotens Aldoster Syst20034945
   PubMed Web of Science ®Google Scholar
• MouradJJWaeberBZannadFComparison of different therapeutic strategies in hypertension: a low-dose combination of perin-dopril/indapamide versus a sequential monotherapy or a stepped-care approachJ Hypertens20042223798615614033
   PubMed Web of Science ®Google Scholar
• RenaudIMChaineyABelairMFLong-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angi-otensin-converting enzyme inhibitor/diuretic combinationFundament Clin Pharmacol20041843747
   PubMed Web of Science ®Google Scholar
• RouxOChapellierMCzernichowSDeterminants of hypertension control in a large French population of treated hypertensive subjectsBlood Press20061561316492610
   PubMed Web of Science ®Google Scholar
• WaeberBMouradJJTargeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertensionAm J Hypertens200619985616942945
   PubMed Web of Science ®Google Scholar
• WilliamsBLacyPSThomSMDifferential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) studyCirculation200611312132516476843
   PubMed Web of Science ®Google Scholar
• Wolf-MaierKCooperRSKramerHHypertension treatment and control in five European countries, Canada, and the United StatesHypertension200443101714638619
   PubMed Web of Science ®Google Scholar